Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / November / New Hope for HighRisk MS Patients / Notecards
Neurology Biochemistry and molecular biology Screening and monitoring Molecular Pathology

New Hope for High-Risk MS Patients

A new study outlines a molecular timeline of myelin and axonal injury that may support earlier detection in high-risk patients

By Kathryn Wighton 11/03/2025 News 2 min read
article Full Article Summary Notecard

Share

  1. Indicators of MS can show years before clinical symptoms.

  2. Myelin injury occurs around 7 years before symptoms, followed by axonal damage a year later.

  3. Astrocytic changes relate to inflammation, occurring upon symptom onset.

  4. Immune signaling pathway alterations noted during presymptomatic stage.

  5. A candidate biomarker panel proposed for early MS detection.

  6. Importance of longitudinal biobanks highlighted.

  7. Potential for improved early detection and monitoring strategies.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.